Evy Vandemeulebroucke

Author

Also Known As

E Vandemeulebroucke, E. Vandemeulebroucke, Evy Vandemeulebroucke, I. Weets, Ilse Weets, K. Decochez, The Belgian Diabetes Registry, Vandemeulebroucke E.

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

KU Leuven Center for Beta Cell Therapy in Diabetes München Klinik Schwabing Erasmus Hospital Inserm

About

Evy Vandemeulebroucke is an author at KU Leuven specializing in diabetes, metabolic syndrome, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	444
2	Diabetes	3	3	444
3	Health Sciences	1	1	310
4	Public Health	1	1	94
5	Epidemiology	1	1	94

Evy Vandemeulebroucke

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
Insulin Needs after CD3-Antibody Therapy in New-Onset Type 1 Diabetes Bart Keymeulen, Evy Vandemeulebroucke, Anette G. Ziegler, New England Journal of Medicine	2005	1.1K
Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass Bart Keymeulen, Melanie Walter, Chantal Mathieu, Diabetologia ObesityMetabolic SyndromeDiabetes ManagementBody CompositionAutoimmune Disease	2010	310
Correlation between β cell mass and glycemic control in type 1 diabetic recipients of islet cell graft Bart Keymeulen, Pieter Gillard, Chantal Mathieu, Proceedings of the National Academy of Sciences	2006	173
IA-2 autoantibodies predict impending Type I diabetes in siblings of patients Katelijn Decochez, I. De Leeuw, Bart Keymeulen, Diabetologia Metabolic SyndromeAutoimmune DiseaseAutoantibody ProductionDiabetesGenetic Epidemiology	2002	94
Transient Epstein-Barr virus reactivation in CD3 monoclonal antibody-treated patients Bart Keymeulen, Sophie Candon, Samira Fafi‐Kremer, Blood	2009	82
Silent iodine prophylaxis in Western Europe only partly corrects iodine deficiency; the case of Belgium François Delange, Anne Van Onderbergen, Wael Shabana, European Journal of Endocrinology	2000	65
Pharmacokinetics and Antibody Responses to the CD3 Antibody Otelixizumab Used in the Treatment of Type 1 Diabetes G Hale, Peppy Rebello, Ibrahim Al Bakir, The Journal of Clinical Pharmacology	2010	46
Insulin treatment in IA-2A-positive relatives of type 1 diabetic patients Evy Vandemeulebroucke, Frans Gorus, Katelijn Decochez, Diabetes & Metabolism Metabolic SyndromeType 1Diabetes ManagementInsulin ManagementDiabetes	2009	40
Functional β-Cell Mass and Insulin Sensitivity Is Decreased in Insulin-Independent Pancreas-Kidney Recipients Pieter Gillard, Evy Vandemeulebroucke, Bart Keymeulen, Transplantation	2009	19
Hyperglycemic Clamp and Oral Glucose Tolerance Test for 3-Year Prediction of Clinical Onset in Persistently Autoantibody-Positive Offspring and Siblings of Type 1 Diabetic Patients Eric V. Balti, Evy Vandemeulebroucke, Ilse Weets, The Journal of Clinical Endocrinology & Metabolism	2014	11

Page 1